EP2908832 - METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.09.2017 Database last updated on 12.11.2024 | |
Former | Request for examination was made Status updated on 01.03.2017 | Most recent event Tooltip | 08.09.2017 | Application deemed to be withdrawn | published on 11.10.2017 [2017/41] | Applicant(s) | For all designated states Polonez Therapeutics LLC 1461 Wrightstown Road Newtown, Pennsylvania 18940 / US | [2015/35] | Inventor(s) | 01 /
BOCHENEK, Wieslaw, J. 1461 Wrightstown Road Newtown, Pennsylvania 18940 / US | 02 /
CORRADO, Michael, L. 1309 Seven Corner Road Perkasie, Pennsylvania 18944 / US | [2015/35] | Representative(s) | Belz, Anna ul. Pólnocna 6/24 20-064 Lublin / PL | [N/P] |
Former [2015/35] | Belz, Anna Polnocna 6/24 20-064 Lublin / PL | Application number, filing date | 13849112.1 | 10.10.2013 | [2015/35] | WO2013US64278 | Priority number, date | US201213657124 | 22.10.2012 Original published format: US201213657124 | [2015/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2014066053 | Date: | 01.05.2014 | Language: | EN | [2014/18] | Type: | A2 Application without search report | No.: | EP2908832 | Date: | 26.08.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.05.2014 takes the place of the publication of the European patent application. | [2015/35] | Search report(s) | International search report - published on: | US | 16.07.2015 | (Supplementary) European search report - dispatched on: | EP | 27.06.2016 | Classification | IPC: | A61K47/00, A61K35/74, A61K36/064, A61K36/06, A61K9/48, A61K45/06, A61K47/32, A61K9/52, A61P31/04 | [2016/30] | CPC: |
A61K9/4891 (EP,US);
A61J1/035 (US);
A61K35/741 (EP,US);
A61K35/742 (US);
A61K35/744 (US);
A61K35/745 (US);
A61K35/747 (US);
A61K36/06 (EP,US);
A61K36/064 (EP,US);
A61K45/06 (EP,US);
A61P1/00 (EP);
A61P1/14 (EP);
| C-Set: |
A61K35/741, A61K2300/00 (EP,US);
A61K36/064, A61K2300/00 (US,EP);
A61K36/06, A61K2300/00 (US,EP)
|
Former IPC [2015/38] | A61K47/00 | ||
Former IPC [2015/35] | A61K35/74, A61K9/50, A61K9/48, A61K9/52, A61K9/20, A61K9/00, A61K36/064, A61K36/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/35] | Title | German: | VERFAHREN ZUR PRÄVENTION UND BEHANDLUNG VON CLOSTRIDIUM DIFFICILE-INFEKTIONEN | [2015/35] | English: | METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION | [2015/35] | French: | PROCÉDÉ DE PRÉVENTION ET DE TRAITEMENT D'UNE INFECTION PAR LE CLOSTRIDIUM DIFFICILE | [2015/35] | Entry into regional phase | 21.05.2015 | National basic fee paid | 21.05.2015 | Search fee paid | 21.05.2015 | Designation fee(s) paid | 21.05.2015 | Examination fee paid | Examination procedure | 21.05.2015 | Examination requested [2015/35] | 29.02.2016 | Amendment by applicant (claims and/or description) | 25.01.2017 | Application deemed to be withdrawn, date of legal effect [2017/41] | 02.03.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/41] | Fees paid | Renewal fee | 26.10.2015 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.10.2016 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]US2007178070 (KAUL POONAM [US], et al) [X] 1-3,5-7 * paragraph [0010] - paragraph [0011]; example 10 * * paragraph [0044] - paragraph [0048] * [Y] 4,8-15; | [XY]WO2011004375 (RUBIN ISRAEL [IL], et al) [X] 1-3,5,7 * page 6, paragraph 2 - page 11, paragraph 1; claims 1-15 * [Y] 4,8-15; | [XI] - MARIYA I. BRACHKOVA ET AL, "Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage forms", JOURNAL OF PHARMACEUTICAL SCIENCES, WASHINGTON, US, (20090901), vol. 98, no. 9, doi:10.1002/jps.21609, ISSN 0022-3549, pages 3329 - 3339, XP055280459 [X] 1-3,5-7 * page 3331, column 2, paragraph 2 - page 3332, column 1, paragraph 3 * * page 3336, column 1, paragraph 3 - page 3338, column 2, paragraph 5 * [I] 1-11 DOI: http://dx.doi.org/10.1002/jps.21609 | [A] - AN THYSSEN ET AL, "Randomized, Open-Label, Single-Dose, Crossover, Relative Bioavailability Study in Healthy Adults, Comparing the Pharmacokinetics of Rabeprazole Granules Administered Using Soft Food or Infant Formula as Dosing Vehicle Versus Suspension", CLINICAL THERAPEUTICS, EXCERPTA MEDICA, PRINCETON, NJ, US, vol. 34, no. 7, doi:10.1016/J.CLINTHERA.2012.06.008, ISSN 0149-2918, (20120606), pages 1636 - 1645, (20120620), XP028405393 [A] 12-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.clinthera.2012.06.008 | International search | [X]US2011240512 (DORFNER SCOTT [US]); | [Y]US2004028689 (BORODY THOMAS JULIUS [AU]); | [Y]US2011020305 (FARMER SEAN [US]); | [Y]WO2011005756 (PURETECH VENTURES LLC [US], et al); | [Y]US2007248582 (LUQUET FRANCOIS-MARIE [FR]) |